- Whose intellectual property is Bharat Biotech’s publicly funded Covaxin? India deserves an answer | If it turns out that the ICMR or the government owns the rights, the Indian public has the right to know how these were leveraged during a pandemic. https://scroll.in/article/993257/why-its-vital-for-indians-to-know-who-owns-intellectual-property-rights-to-bharat-biotechs-covaxin 3 comments india
- Whose intellectual property is Bharat Biotech’s publicly funded Covaxin? India deserves an answer https://scroll.in/article/993257/why-its-vital-for-indians-to-know-who-owns-intellectual-property-rights-to-bharat-biotechs-covaxin 15 comments india
Linked pages
- Oxford/AstraZeneca Covid vaccine research ‘was 97% publicly funded’ | Medical research | The Guardian https://www.theguardian.com/science/2021/apr/15/oxfordastrazeneca-covid-vaccine-research-was-97-publicly-funded 82 comments
- ICMR Letter Says Bharat Biotech Working to Deliver Covid-19 Vaccine by August 15, Experts Warn against Shortcuts https://www.news18.com/news/india/icmr-heads-letter-says-launch-of-bharat-biotechs-covid-19-vaccine-latest-by-august-15-2698755.html 10 comments
- Oxford’s COVID vaccine deal with AstraZeneca raises concerns about access and pricing | Fortune https://fortune.com/2020/08/24/oxford-astrazeneca-covid-vaccine-deal-pricing-profit-concerns/ 6 comments
Related searches:
Search whole site: site:scroll.in
Search title: Covid-19 vaccine: Who owns the IP rights to Bharat Biotech’s publicly funded Covaxin?
See how to search.